REPORT ID 6968

EMEA (Europe, Middle East and Africa) Desloratadine Market Report 2017

Publish Date
1-Nov-17
Pages
113
Format
Electronic (PDF)

In this report, the EMEA Desloratadine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Desloratadine for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Desloratadine market competition by top manufacturers/players, with Desloratadine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Teva
    Wante Pharmaceutical
    Novartis India Limited
    Mylan
    Sepracor
    Sandoz
    Apollo Pharmaceuticals
    GSK
    Mayne Pharma Inc
    Abhilasha Pharma Pvt
    Abbott
    Takeda
    Schering-Plough
    Nanjing Hicin Pharmaceutical
    Hairui Pharmaceutical
    Hainan Poly Pharm
    Shenzhen Salubris Pharmaceuticals
    Shenzhen Haibin Pharmaceutical

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Injection
    Freeze-dried powder

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Desloratadine for each application, including
    Hospital use
    Clinic
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Desloratadine Market Report 2017
1 Desloratadine Overview
    1.1 Product Overview and Scope of Desloratadine
    1.2 Classification of Desloratadine
        1.2.1 EMEA Desloratadine Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Desloratadine Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Injection
        1.2.4 Freeze-dried powder
    1.3 EMEA Desloratadine Market by Application/End Users
        1.3.1 EMEA Desloratadine Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital use
        1.3.3 Clinic
        1.3.4 Others
    1.4 EMEA Desloratadine Market by Region
        1.4.1 EMEA Desloratadine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Desloratadine (2012-2022)
        1.5.1 EMEA Desloratadine Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Desloratadine Revenue and Growth Rate (2012-2022)

2 EMEA Desloratadine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Desloratadine Market Competition by Players/Manufacturers
        2.1.1 EMEA Desloratadine Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Desloratadine Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Desloratadine Sale Price by Players (2012-2017)
    2.2 EMEA Desloratadine (Volume and Value) by Type/Product Category
        2.2.1 EMEA Desloratadine Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Desloratadine Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Desloratadine Sale Price by Type (2012-2017)
    2.3 EMEA Desloratadine (Volume) by Application
    2.4 EMEA Desloratadine (Volume and Value) by Region
        2.4.1 EMEA Desloratadine Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Desloratadine Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Desloratadine Sales Price by Region (2012-2017)

3 Europe Desloratadine (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Desloratadine Sales and Value (2012-2017)
        3.1.1 Europe Desloratadine Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Desloratadine Revenue and Growth Rate (2012-2017)
    3.2 Europe Desloratadine Sales and Market Share by Type
    3.3 Europe Desloratadine Sales and Market Share by Application
    3.4 Europe Desloratadine Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Desloratadine Sales Volume by Countries (2012-2017)
        3.4.2 Europe Desloratadine Revenue by Countries (2012-2017)
        3.4.3 Germany Desloratadine Sales and Growth Rate (2012-2017)
        3.4.4 France Desloratadine Sales and Growth Rate (2012-2017)
        3.4.5 UK Desloratadine Sales and Growth Rate (2012-2017)
        3.4.6 Russia Desloratadine Sales and Growth Rate (2012-2017)
        3.4.7 Italy Desloratadine Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Desloratadine Sales and Growth Rate (2012-2017)

4 Middle East Desloratadine (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Desloratadine Sales and Value (2012-2017)
        4.1.1 Middle East Desloratadine Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Desloratadine Revenue and Growth Rate (2012-2017)
    4.2 Middle East Desloratadine Sales and Market Share by Type
    4.3 Middle East Desloratadine Sales and Market Share by Application
    4.4 Middle East Desloratadine Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Desloratadine Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Desloratadine Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Desloratadine Sales and Growth Rate (2012-2017)
        4.4.4 Israel Desloratadine Sales and Growth Rate (2012-2017)
        4.4.5 UAE Desloratadine Sales and Growth Rate (2012-2017)
        4.4.6 Iran Desloratadine Sales and Growth Rate (2012-2017)

5 Africa Desloratadine (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Desloratadine Sales and Value (2012-2017)
        5.1.1 Africa Desloratadine Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Desloratadine Revenue and Growth Rate (2012-2017)
    5.2 Africa Desloratadine Sales and Market Share by Type
    5.3 Africa Desloratadine Sales and Market Share by Application
    5.4 Africa Desloratadine Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Desloratadine Sales Volume by Countries (2012-2017)
        5.4.2 Africa Desloratadine Revenue by Countries (2012-2017)
        5.4.3 South Africa Desloratadine Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Desloratadine Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Desloratadine Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Desloratadine Sales and Growth Rate (2012-2017)

6 EMEA Desloratadine Manufacturers/Players Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Desloratadine Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Desloratadine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Teva
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Desloratadine Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Teva Desloratadine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Wante Pharmaceutical
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Desloratadine Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Wante Pharmaceutical Desloratadine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Novartis India Limited
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Desloratadine Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Novartis India Limited Desloratadine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Mylan
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Desloratadine Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Mylan Desloratadine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Sepracor
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Desloratadine Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Sepracor Desloratadine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Sandoz
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Desloratadine Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Sandoz Desloratadine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Apollo Pharmaceuticals
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Desloratadine Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Apollo Pharmaceuticals Desloratadine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 GSK
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Desloratadine Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 GSK Desloratadine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Mayne Pharma Inc
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Desloratadine Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Mayne Pharma Inc Desloratadine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Abhilasha Pharma Pvt
    6.12 Abbott
    6.13 Takeda
    6.14 Schering-Plough
    6.15 Nanjing Hicin Pharmaceutical
    6.16 Hairui Pharmaceutical
    6.17 Hainan Poly Pharm
    6.18 Shenzhen Salubris Pharmaceuticals
    6.19 Shenzhen Haibin Pharmaceutical

7 Desloratadine Manufacturing Cost Analysis
    7.1 Desloratadine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Desloratadine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Desloratadine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Desloratadine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Desloratadine Market Forecast (2017-2022)
    11.1 EMEA Desloratadine Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Desloratadine Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Desloratadine Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Desloratadine Price and Trend Forecast (2017-2022)
    11.2 EMEA Desloratadine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Desloratadine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Desloratadine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Desloratadine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Desloratadine Sales Forecast by Type (2017-2022)
    11.7 EMEA Desloratadine Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer